Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.
Bertero E, Chiti C, Schiavo MA, Tini G, Costa P, Todiere G, Mabritto B, Dei LL, Giannattasio A, Mariani D, Lofiego C, Santolamazza C, Monda E, Quarta G, Barbisan D, Mandoli GE, Mapelli M, Sguazzotti M, Negri F, De Vecchi S, Ciabatti M, Tomasoni D, Mazzanti A, Marzo F, de Gregorio C, Raineri C, Vianello PF, Marchi A, Biagioni G, Insinna E, Parisi V, Ditaranto R, Barison A, Giammarresi A, De Ferrari GM, Priori S, Metra M, Pieroni M, Patti G, Imazio M, Perugini E, Agostoni P, Cameli M, Merlo M, Sinagra G, Senni M, Limongelli G, Ammirati E, Vagnarelli F, Crotti L, Badano L, Calore C, Gabrielli D, Re F, Musumeci G, Emdin M, Barbato E, Musumeci B, Autore C, Biagini E, Porto I, Olivotto I, Canepa M. Bertero E, et al. Among authors: mabritto b. Eur J Heart Fail. 2024 Jan;26(1):59-64. doi: 10.1002/ejhf.3120. Epub 2024 Jan 2. Eur J Heart Fail. 2024. PMID: 38131253 Clinical Trial.
Effectiveness of 2014 ESC HCM-Risk-SCD score in prediction of appropriate implantable-cardioverter-defibrillator shocks.
Buongiorno AL, Blandino A, Bianchi F, Masi AS, Pierri A, Mabritto B, Bongioanni S, Grossi S, Mascia G, Porto I, Musumeci G. Buongiorno AL, et al. Among authors: mabritto b. J Cardiovasc Med (Hagerstown). 2023 May 1;24(5):313-314. doi: 10.2459/JCM.0000000000001458. Epub 2023 Mar 20. J Cardiovasc Med (Hagerstown). 2023. PMID: 36957982 No abstract available.
[The importance of intensive lipid-lowering therapy after acute coronary syndrome: changing the paradigm to improve the achievement of targets].
Muccioli S, Giglio C, Annibali G, Cerutti E, Civera S, Casati R, Delnevo F, De Rosa C, Bongioanni S, Colopi M, Gandolfo N, Aranzulla T, Bianchi F, Blandino A, Borrione M, Grossi S, Luceri S, Mabritto B, Carceri C, Meliga E, Parrini I, Pizzuti A, Scrocca I, Sibona Masi A, Tomasello A, Gasco A, Musumeci G. Muccioli S, et al. Among authors: mabritto b. G Ital Cardiol (Rome). 2022 Jul;23(7):553-561. doi: 10.1714/3831.38173. G Ital Cardiol (Rome). 2022. PMID: 35771021 Italian.
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, Maggioni AP, Masson S, Mureddu GF, Tarantini L, Velussi M, Comaschi M; DYDA Investigators. Cioffi G, et al. Eur J Prev Cardiol. 2012 Oct;19(5):935-43. doi: 10.1177/1741826711417759. Epub 2011 Jul 28. Eur J Prev Cardiol. 2012. PMID: 21798988